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To the Editor: 
 
We read with interest the article "Solid Tumors After Heart Transplantation: Lethality 
of Lung Cancer" by Pham and associates [1]. This excellent report examines the 
development of solid-organ tumors after cardiac transplantation and identifies 38 solid 
tumors in 36 of 608 heart transplant recipients. Skin tumors are identified in 15 patients, 
which represents a frequency of 2.1%. 
 
We have recently reported our experience in skin cancer after heart transplantation in 92 
heart transplant recipients who survived more than 6 months after the operation, with an 
average follow-up period of 43.3 months [2]. In our series, 26 skin cancers were found 
in 14 patients, which represents a frequency of 15.2%. In addition, more than one skin 
cancer developed in 5 of the 14 patients during follow-up, whereas common warts and 
keratotic and dysplastic lesions were observed and treated on photoexposed areas in 
many of the 14 patients. 
 
Several factors probably account for the higher frequency of skin cancer observed in our 
patients compared with the results of Pham and associates. It is important to consider 
geographic factors such as the country, latitude, and amount of exposure to ultraviolet 
radiation. Most of our patients carne from the northern and eastern regions of Spain. It 
is known that residents of sunny countries have a higher frequency of skin cancer than 
those living in countries with less solar radiation. On the other hand, patient 
characteristics such as skin type, pretransplantation exposure to ultraviolet radiation, 
posttransplantation period, immunosuppressive treatment, patient age, and dysplastic 
lesions are all important factors that may contribute to generate different skin cancer 
frequencies after transplantation. Pretransplantation exposure to sunlight must be 
considered because skin cancer may arise earlier in keratinocytes that have been 
previously damaged by ultraviolet radiation.  
 
We found that the cumulative incidence of skin cancer increased as follow-up 
progressed, although surprisingly the time lapse for basal cell carcinoma was less than 
for squamous cell carcinoma, and the ratio of basal cell carcinoma to squamous cell 
carcinoma inverted as follow-up progressed. In this sense, it has been observed in renal 
allograft recipients that azathioprine induces the appearance of keratotic and dysplastic 
lesions approximately 3 to 4 years after administration, and squamous lesions may 
develop tater on [31. We agree with Pham and associates that skin cancer after heart 
transplantation has a low mortality, that cardiac transplant recipients should be advised 
to minimize exposure to sunlight, and that the long-term use of azathioprine should be 
reconsidered. Nevertheless, we believe that in sunny countries the higher incidence of 
skin cancer warrants a more aggressive prevention of skin cancer and treatment of 
suspected premalignant lesions. In this sense, our protocol includes dermatologic 
examinations every 6 months, the regular use of sunblocks, prompt treatment of all 
suspicious lesions, and the reduction of azathioprine doses, particularly in older patients 
with long-term posttransplantation follow-up. 
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